Pyongyang, March 14 (KCNA) — Should the south Korean authorities sign FTA with the U.S., the production of medicines, etc. in south Korea will be restricted by the pharmaceutical companies of the U.S., which will immediately lead to skyrocketing prices of medicines.
Twelve health organizations including the Pharmacists Association for a Healthy Society said this at a news conference held on Mar. 9 in Seoul demanding an immediate halt to the negotiations for the conclusion of FTA.
They warned that the signing of FTA would lead to the commercialization of the health system to widen the gap between the rich and the poor and aggravate social antagonism, the south Korean KBS said.
Image credit: https://www.flickr.com/photos/pricey/516493127/